Sponsor
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
Posted
India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Pakistan earthquake: 5.4 magnitude tremor jolts several areas; no damage reported
A 5.4 magnitude earthquake jolted Pakistan early Saturday, triggering widespread panic across...
‘Quality education pays off’
KANCHANPUR: Nepali Congress leader NP Saud has said that investment in quality education provides...
Boy electrocuted in Baitadi
BAITADI: A boy was electrocuted in Baitadi district today. The deceased is 13-year old Kiran...
Trump tariff drag on Warren Buffett’s business: Berkshire Hathaway profit halves after $3.76bn Kraft Heinz writedown; Q2 net slips to $12.37bn from $30.25bn YoY
Berkshire Hathaway's second-quarter profit plummeted 59% to $12.37 billion, impacted by a $3.76...